- Home
- SB vs HQL Comparison
SB vs HQL Comparison
Compare SB & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SB
- HQL
- Stock Information
- Founded
- SB 2007
- HQL 1992
- Country
- SB Monaco
- HQL United States
- Employees
- SB N/A
- HQL N/A
- Industry
- SB Marine Transportation
- HQL Investment Managers
- Sector
- SB Consumer Discretionary
- HQL Finance
- Exchange
- SB Nasdaq
- HQL Nasdaq
- Market Cap
- SB 454.8M
- HQL 375.2M
- IPO Year
- SB 2008
- HQL N/A
- Fundamental
- Price
- SB $4.26
- HQL $13.75
- Analyst Decision
- SB
- HQL
- Analyst Count
- SB 0
- HQL 0
- Target Price
- SB N/A
- HQL N/A
- AVG Volume (30 Days)
- SB 531.7K
- HQL 120.9K
- Earning Date
- SB 11-13-2024
- HQL 01-01-0001
- Dividend Yield
- SB 4.68%
- HQL 11.56%
- EPS Growth
- SB 35.10
- HQL N/A
- EPS
- SB 0.90
- HQL 0.79
- Revenue
- SB $318,430,000.00
- HQL N/A
- Revenue This Year
- SB $9.46
- HQL N/A
- Revenue Next Year
- SB N/A
- HQL N/A
- P/E Ratio
- SB $4.76
- HQL $17.08
- Revenue Growth
- SB 10.27
- HQL N/A
- 52 Week Low
- SB $3.45
- HQL $11.34
- 52 Week High
- SB $6.33
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- SB 40.09
- HQL 25.43
- Support Level
- SB $4.31
- HQL $15.06
- Resistance Level
- SB $4.44
- HQL $15.37
- Average True Range (ATR)
- SB 0.10
- HQL 0.26
- MACD
- SB 0.03
- HQL -0.09
- Stochastic Oscillator
- SB 44.12
- HQL 2.99
About SB Safe Bulkers Inc ($0.001 par value)
Safe Bulkers Inc is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain and iron ore, along international shipping routes for consumers of marine drybulk transportation services. The company employs its vessels on both period time charters and spot time charters, according to the assessment of market conditions, with consumers of marine drybulk transportation services.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing primarily in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have significant potential for above-average growth.